{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:30:04Z","timestamp":1793853004237,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project MNESYS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-026-02344-9","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:55:00Z","timestamp":1775292900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Migraine in pediatric population: the role of biochemical markers"],"prefix":"10.1186","volume":"27","author":[{"given":"Gabriele","family":"Monte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Ursitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Papetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"key":"2344_CR1","doi-asserted-by":"publisher","unstructured":"Onofri A, Pensato U, Rosignoli C, Wells-Gatnik W, Stanyer E, Ornello R et al (2023) Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis. J Headache Pain 24(1):8. https:\/\/doi.org\/10.1186\/s10194-023-01541-0. European Headache Federation School of Advanced Studies (EHF-SAS)","DOI":"10.1186\/s10194-023-01541-0"},{"key":"2344_CR2","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"10283","key":"2344_CR3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al\u2013Mahdi Al\u2013Karagholi M, de Boer I, Lee MJ et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496\u20131504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0","journal-title":"Lancet"},{"issue":"6","key":"2344_CR4","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.3390\/ijms24065334","volume":"24","author":"C Demartini","year":"2023","unstructured":"Demartini C, Francavilla M, Zanaboni AM, Facchetti S, De Icco R, Martinelli D et al (2023) Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings. Int J Mol Sci 24(6):5334. https:\/\/doi.org\/10.3390\/ijms24065334","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2344_CR5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar S, Johnson KW, Ossipov MH, Aurora SK (2019) CGRP and the Trigeminal System in Migraine. Headache 59(5):659\u2013681. https:\/\/doi.org\/10.1111\/head.13529","journal-title":"Headache"},{"issue":"1","key":"2344_CR6","doi-asserted-by":"publisher","first-page":"e70177","DOI":"10.1002\/ejp.70177","volume":"30","author":"G Zhu","year":"2026","unstructured":"Zhu G, Yan G, Luo Y, Luo J (2026) Calcitonin Gene-Related Peptide (CGRP) Levels of Children and Adolescents with Migraine: A Systematic Review and Meta-Analysis of Observational Studies. Eur J Pain 30(1):e70177. https:\/\/doi.org\/10.1002\/ejp.70177","journal-title":"Eur J Pain"},{"key":"2344_CR7","doi-asserted-by":"publisher","first-page":"105946","DOI":"10.1016\/j.nbd.2022.105946","volume":"176","author":"S Guo","year":"2023","unstructured":"Guo S, Jansen-Olesen I, Olesen J, Christensen SL (2023) Role of PACAP in migraine: An alternative to CGRP? Neurobiol Dis 176:105946. https:\/\/doi.org\/10.1016\/j.nbd.2022.105946","journal-title":"Neurobiol Dis"},{"key":"2344_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1096531","author":"Z Chen","year":"2022","unstructured":"Chen Z, Chen X, Fan Y (2022) Biomarkers in migraine beyond diagnosis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.1096531","journal-title":"Front Neurol"},{"issue":"10","key":"2344_CR9","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/head.14981","volume":"65","author":"SA Orak","year":"2025","unstructured":"Orak SA, Polat M, Pak M, \u00c7er\u00e7i Kubur C, Atasever AK, Yilmaz C et al (2025) Can serum neuropeptide levels help diagnose pediatric migraine? A prospective case-control study. Headache 65(10):1821\u20131830. https:\/\/doi.org\/10.1111\/head.14981","journal-title":"Headache"},{"issue":"1","key":"2344_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s10194-025-02136-7","volume":"26","author":"E Stuchfield-Denby","year":"2025","unstructured":"Stuchfield-Denby E, Pereira B, Bouvier D, Dallel R, Moisset X (2025) Distinct inflammatory profiles across migraine states: a systematic review and meta-analysis. Meta-Analysis J Headache Pain 26(1):219. https:\/\/doi.org\/10.1186\/s10194-025-02136-7","journal-title":"Meta-Analysis J Headache Pain"},{"issue":"8","key":"2344_CR11","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/head.14618","volume":"63","author":"YB Kilinc","year":"2023","unstructured":"Kilinc YB, Kilinc E, Danis A, Hanci F, Turay S, Ozge A, Bolay H (2023) Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1\u03b1 are elevated in pediatric migraine attacks. Headache 63(8):1076\u20131086. https:\/\/doi.org\/10.1111\/head.14618","journal-title":"Headache"},{"issue":"1","key":"2344_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s10194-024-01871-7","volume":"25","author":"L Papetti","year":"2024","unstructured":"Papetti L, Del Chierico F, Frattale I, Toto F, Scanu M, Levi Mortera S et al (2024) Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation. J Headache Pain 25(1):171. https:\/\/doi.org\/10.1186\/s10194-024-01871-7","journal-title":"J Headache Pain"},{"issue":"6","key":"2344_CR13","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe 23(6):716\u2013724. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003","journal-title":"Cell Host Microbe"},{"issue":"7","key":"2344_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/jcm8070928","volume":"8","author":"L Gallelli","year":"2019","unstructured":"Gallelli L, Cione E, Peltrone F, Siviglia S, Verano A, Chirchiglia D et al (2019) Has-miR\u201334a\u20135p and hsa\u2013miR\u2013375 as biomarkers for monitoring the effects of drug treatment for migraine pain in children and adolescents: A pilot study. J Clin Med 8(7):928. https:\/\/doi.org\/10.3390\/jcm8070928","journal-title":"J Clin Med"},{"issue":"12","key":"2344_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jcph.2331","volume":"63","author":"HM Puliappadamb","year":"2023","unstructured":"Puliappadamb HM, Satpathy AK, Mishra BR, Maiti R, Jena M (2023) Evaluation of Safety and Efficacy of Add-on Alpha-Lipoic Acid on Migraine Prophylaxis in an Adolescent Population: A Randomized Controlled Trial. Clin Pharmacol 63(12):1398\u20131407. https:\/\/doi.org\/10.1002\/jcph.2331","journal-title":"Clin Pharmacol"},{"issue":"5","key":"2344_CR16","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1468-2982.1995.1505384.x","volume":"15","author":"V Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G et al (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15(5):384\u2013390. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.1505384.x","journal-title":"Cephalalgia"},{"issue":"8","key":"2344_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1468-2982.2008.01816.x","volume":"29","author":"PC Fan","year":"2009","unstructured":"Fan PC, Kuo PH, Chang SH, Lee WT, Wu RM, Chiou LC (2009) Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Cephalalgia 29(8):883\u2013890. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01816.x","journal-title":"Cephalalgia"},{"issue":"2","key":"2344_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0333102420957588","volume":"41","author":"F Hanci","year":"2021","unstructured":"Hanci F, Kilinc YB, Kilinc E, Turay S, Dilek M, Kabakus N (2021) Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods. Cephalalgia 41(2):166\u2013175. https:\/\/doi.org\/10.1177\/0333102420957588","journal-title":"Cephalalgia"},{"issue":"1","key":"2344_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-022-01435-7","volume":"23","author":"J Liu","year":"2022","unstructured":"Liu J, Wang G, Dan Y, Liu X (2022) CGRP and PACAP-38 play an important role in diagnosing pediatric migraine. J Headache Pain 23(1):68. https:\/\/doi.org\/10.1186\/s10194-022-01435-7","journal-title":"J Headache Pain"},{"issue":"23","key":"2344_CR20","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.3390\/diagnostics14232645","volume":"14","author":"JS Fures","year":"2024","unstructured":"Fures JS, Duranovic V, Lenicek Krleza J, Katusic Bojanac A, Loncar L, Dakovic I et al (2024) Calcitonin-Gene-Related Peptide in Migraine and Tension-Type Headache in Children During Interictal Period. Diagnostics (Basel) 14(23):2645. https:\/\/doi.org\/10.3390\/diagnostics14232645","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"2344_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/08830738251321276","volume":"40","author":"MM Falsing","year":"2025","unstructured":"Falsing MM, Berring-Uldum AA, F\u00f8rland-Schill A, J\u00f8rgensen NR, Monique Debes NM (2025) Calcitonin Gene-Related Peptide Levels in Children and Adolescents with Primary Headache Disorder. J Child Neurol 40(6):439\u2013447. https:\/\/doi.org\/10.1177\/08830738251321276","journal-title":"J Child Neurol"},{"issue":"1","key":"2344_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1055\/s-0044-1788787","volume":"56","author":"H Aydin","year":"2025","unstructured":"Aydin H, Baykan O (2025) The Role of Calcitonin Gene-Related Peptide and Amylin in Pediatric Migraine. Neuropediatrics 56(1):29\u201333. https:\/\/doi.org\/10.1055\/s-0044-1788787","journal-title":"Neuropediatrics"},{"key":"2344_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00010","author":"PC Fan","year":"2019","unstructured":"Fan PC, Kuo PH, Lee MT, Chang SH, Chiou LC (2019) Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00010","journal-title":"Front Neurol"},{"issue":"1","key":"2344_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1526-4610.1994.hed3401035.x","volume":"34","author":"V Gallai","year":"1994","unstructured":"Gallai V, Sarchielli P, Trequattrini A, Paciaroni M, Usai F, Palumbo R (1994) Neuropeptide Y in juvenile migraine and tension-type headache. Headache 34(1):35\u201340. https:\/\/doi.org\/10.1111\/j.1526-4610.1994.hed3401035.x","journal-title":"Headache"},{"issue":"10","key":"2344_CR25","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/j.1526-4610.2009.01392.x","volume":"49","author":"A Pakalnis","year":"2009","unstructured":"Pakalnis A, Splaingard M, Splaingard D, Kring D, Colvin A (2009) Serotonin effects on sleep and emotional disorders in adolescent migraine. Headache 49(10):1486\u20131492. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01392.x","journal-title":"Headache"},{"issue":"1","key":"2344_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10194-023-01708-9","volume":"25","author":"J Liu","year":"2024","unstructured":"Liu J, Xi K, Zhang L, Han M, Wang Q, Liu X (2024) Tryptophan metabolites and gut microbiota play an important role in pediatric migraine diagnosis. J Headache Pain 25(1):2. https:\/\/doi.org\/10.1186\/s10194-023-01708-9","journal-title":"J Headache Pain"},{"key":"2344_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejpn.2025.07.003","volume":"58","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang Y, Zhang J, Jiang C (2025) Association of 5-HT, ET-1, PTX-3, and inflammatory markers with clinical parameters in pediatric migraine patients with patent foramen ovale. Eur J Paediatr Neurol 58:14\u201319. https:\/\/doi.org\/10.1016\/j.ejpn.2025.07.003","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"2344_CR28","doi-asserted-by":"publisher","first-page":"2606487","DOI":"10.1080\/19490976.2025.2606487","volume":"18","author":"PC Fan","year":"2025","unstructured":"Fan PC, Chua HH, Lin CR, Lai TH, Chiou LC, Lee WT et al (2025) Targeting the microbiome in pediatric migraine: gastrointestinal manifestations and the therapeutic role of Bifidobacterium longum. Gut Microbes 18(1):2606487. https:\/\/doi.org\/10.1080\/19490976.2025.2606487","journal-title":"Gut Microbes"},{"issue":"9","key":"2344_CR29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1468-2982.2008.01630.x","volume":"28","author":"F Alehan","year":"2008","unstructured":"Alehan F, Oz\u00e7ay F, Erol I, Canan O, Cemil T (2008) Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia 28(9):945\u2013949. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01630.x","journal-title":"Cephalalgia"},{"issue":"3","key":"2344_CR30","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.braindev.2025.104359","volume":"47","author":"SS \u015eahin","year":"2025","unstructured":"\u015eahin SS, Hataysal EP, Karatoprak EY, Oval\u0131 F, \u00d6zel A, Duranku\u015f F, Vatansev H (2025) Tryptophan metabolism in children with migraine: The role of kynurenine pathway. Brain Dev 47(3):104359. https:\/\/doi.org\/10.1016\/j.braindev.2025.104359","journal-title":"Brain Dev"},{"issue":"1","key":"2344_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pediatrneurol.2009.02.001","volume":"41","author":"L Bo\u0107kowski","year":"2009","unstructured":"Bo\u0107kowski L, Sobaniec W, Zelazowska-Rutkowska B (2009) Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol 41(1):17\u201321. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.02.001","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2344_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2009.04.019","volume":"41","author":"T Hirfanoglu","year":"2009","unstructured":"Hirfanoglu T, Serdaroglu A, Gulbahar O, Cansu A (2009) Prophylactic drugs and cytokine and leptin levels in children with migraine. Pediatr Neurol 41(4):281\u2013287. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.04.019","journal-title":"Pediatr Neurol"},{"key":"2344_CR33","doi-asserted-by":"publisher","first-page":"151347387","DOI":"10.3389\/fneur.2024.1347387","volume":"31","author":"F Yang","year":"2024","unstructured":"Yang F, Liu HZ, Liu JA, Chen YY, Sun SZ (2024) Study on the correlation between IL-12p70, IL-17A and migraine in children. Front Neurol 31:151347387. https:\/\/doi.org\/10.3389\/fneur.2024.1347387","journal-title":"Front Neurol"},{"issue":"2","key":"2344_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s1734-1140(10)70268-1","volume":"62","author":"L Bo\u0107kowski","year":"2010","unstructured":"Bo\u0107kowski L, Smigielska-Kuzia J, Sobaniec W, Zelazowska-Rutkowska B, Ku\u0142ak W, Sendrowski K (2010) Anti-inflammatory plasma cytokines in children and adolescents with migraine headaches. Pharmacol Rep 62(2):287\u2013291. https:\/\/doi.org\/10.1016\/s1734-1140(10)70268-1","journal-title":"Pharmacol Rep"},{"issue":"10","key":"2344_CR35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s10072-016-2648-0","volume":"37","author":"HG Poyrazoglu","year":"2016","unstructured":"Poyrazoglu HG, Vurdem UE, Arslan A, Uytun S (2016) Evaluation of carotid intima-media thickness in children with migraine: a marker of subclinical atherosclerosis. Neurol Sci 37(10):1663\u20131669. https:\/\/doi.org\/10.1007\/s10072-016-2648-0","journal-title":"Neurol Sci"},{"issue":"1","key":"2344_CR36","doi-asserted-by":"publisher","first-page":"e14946","DOI":"10.1111\/ped.14946","volume":"64","author":"I Polat","year":"2022","unstructured":"Polat I, Karao\u011flu P, \u015ei\u015fman AR, Yi\u015f U, H\u0131z Kurul S (2022) Inflammation and endothelial dysfunction in pediatric migraine patients. Pediatr Int 64(1):e14946. https:\/\/doi.org\/10.1111\/ped.14946","journal-title":"Pediatr Int"},{"issue":"4","key":"2344_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s13760-019-01106-6","volume":"120","author":"HG Poyrazo\u011flu","year":"2020","unstructured":"Poyrazo\u011flu HG, \u00d6zt\u00fcrk AB (2020) Predictive value of laboratory parameters in childhood migraine. Acta Neurol Belg 120(4):907\u2013914. https:\/\/doi.org\/10.1007\/s13760-019-01106-6","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"2344_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/ane.12263","volume":"130","author":"H Ince","year":"2014","unstructured":"Ince H, Aydin OF, Ala\u00e7am H, Aydin T, Azak E, \u00d6zy\u00fcrek H (2014) Urinary leukotriene E4 and prostaglandin F2a concentrations in children with migraine: a randomized study. Acta Neurol Scand 130(3):188\u2013192. https:\/\/doi.org\/10.1111\/ane.12263","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2344_CR39","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","volume":"103","author":"AF Russo","year":"2023","unstructured":"Russo AF, Hay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103(2):1565\u20131644. https:\/\/doi.org\/10.1152\/physrev.00059.2021","journal-title":"Physiol Rev"},{"issue":"6","key":"2344_CR40","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14(6):338\u2013350. https:\/\/doi.org\/10.1038\/s41582-018-0003-1","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"2344_CR41","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n E, Larrosa D, Ramon C, Vega J, Mart\u00ednez-Camblor P, Pascual J (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81(14):1191\u20131196. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a6cb72","journal-title":"Neurology"},{"issue":"12","key":"2344_CR42","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1469-8749.2010.03793.x","volume":"52","author":"I Abu-Arafeh","year":"2010","unstructured":"Abu-Arafeh I, Razak S, Sivaraman B, Graham C (2010) Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 52(12):1088\u20131097. https:\/\/doi.org\/10.1111\/j.1469-8749.2010.03793.x","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"2344_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455\u2013464. https:\/\/doi.org\/10.1038\/nrneurol.2016.93","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"2344_CR44","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa2314577","volume":"391","author":"M Ashina","year":"2024","unstructured":"Ashina M, Phul R, Khodaie M, Lof E, Florea I (2024) A Monoclonal Antibody to PACAP for Migraine Prevention. N Engl J Med 391(9):800\u2013809. https:\/\/doi.org\/10.1056\/NEJMoa2314577","journal-title":"N Engl J Med"},{"issue":"Pt 3","key":"2344_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM, Hougaard A, Schytz HW, Asghar MS, Lundholm E, Parvaiz AI et al (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137(Pt 3):779\u2013794. https:\/\/doi.org\/10.1093\/brain\/awt369","journal-title":"Brain"},{"issue":"2","key":"2344_CR46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/WNR.0000000000001569","volume":"32","author":"J Liang","year":"2021","unstructured":"Liang J, Zhou X, Wang J, Fei ZY, Qin GC, Zhang DK et al (2021) Upregulation of silent information regulator 1 alleviates mitochondrial dysfunction in the trigeminal nucleus caudalis in a rat model of chronic migraine. NeuroReport 32(2):144\u2013156. https:\/\/doi.org\/10.1097\/WNR.0000000000001569","journal-title":"NeuroReport"},{"issue":"1","key":"2344_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s10194-024-01908-x","volume":"25","author":"J Kordacka","year":"2024","unstructured":"Kordacka J, Gruszka R, Zakrzewska M (2024) Serum microRNA qPCR profiling and validation indicate upregulation of circulating miR-145-5p and miR-26a-5p in migraineurs. J Headache Pain 25(1):198. https:\/\/doi.org\/10.1186\/s10194-024-01908-x","journal-title":"J Headache Pain"},{"issue":"14","key":"2344_CR48","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2174\/011570159X341703250130064735","volume":"23","author":"S Ahmad","year":"2025","unstructured":"Ahmad S, Wang L, Zafar I, Abbas Z, Unar A, Mohany M et al (2025) Informatics Approach Towards Targeting HTR1B Pathways in Neuropharmacology for Migraine Treatment. Curr Neuropharmacol 23(14):1939\u20131961. https:\/\/doi.org\/10.2174\/011570159X341703250130064735","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"2344_CR49","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-023-01609-x","volume":"24","author":"Q He","year":"2023","unstructured":"He Q, Wang W, Xiong Y, Tao C, Ma L, Ma J, You C, International Headache Genetics Consortium (2023) A causal effects of gut microbiota in the development of migraine. J Headache Pain 24(1):90. https:\/\/doi.org\/10.1186\/s10194-023-01609-x","journal-title":"J Headache Pain"},{"issue":"1","key":"2344_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s10194-024-01833-z","volume":"25","author":"T Kortesi","year":"2024","unstructured":"Kortesi T, Nagy-Grocz G, Vecsei L (2024) The role of kynurenines in migraine-related neuroimmune pathways. J Headache Pain 25(1):129. https:\/\/doi.org\/10.1186\/s10194-024-01833-z","journal-title":"J Headache Pain"},{"issue":"10","key":"2344_CR51","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s10072-018-3493-0","volume":"39","author":"F Martami","year":"2018","unstructured":"Martami F, Razeghi Jahromi S, Togha M, Ghorbani Z, Seifishahpar M, Saidpour A (2018) The serum level of inflammatory markers in chronic and episodic migraine: a case-control study. Neurol Sci 39(10):1741\u20131749. https:\/\/doi.org\/10.1007\/s10072-018-3493-0","journal-title":"Neurol Sci"},{"key":"2344_CR52","doi-asserted-by":"publisher","first-page":"120311","DOI":"10.1016\/j.jad.2025.120311","volume":"392","author":"S Hu","year":"2026","unstructured":"Hu S, Tang Z, Ouyang X, Sun S, Xu L, Yuan J, Zhao L (2026) Peripheral innate immune signature links migraine and depression: Identification of PTX3 and HP as shared diagnostic biomarkers. J Affect Disord 392:120311. https:\/\/doi.org\/10.1016\/j.jad.2025.120311","journal-title":"J Affect Disord"},{"issue":"8","key":"2344_CR53","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/03331024221075616","volume":"42","author":"J Kim","year":"2022","unstructured":"Kim J, Park CG, Chu MK (2022) Interictal plasma endothelin-1 levels do not change in individuals with episodic and chronic migraine. Cephalalgia 42(8):761\u2013768. https:\/\/doi.org\/10.1177\/03331024221075616","journal-title":"Cephalalgia"},{"issue":"3","key":"2344_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WCO.0b013e328360864b","volume":"26","author":"M Antonova","year":"2013","unstructured":"Antonova M, Wienecke T, Olesen J, Ashina M (2013) Prostaglandins in migraine: update. Curr Opin Neurol 26(3):269\u2013275. https:\/\/doi.org\/10.1097\/WCO.0b013e328360864b","journal-title":"Curr Opin Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02344-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:45:03Z","timestamp":1775565903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02344-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02344-9","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GM, CG, FU, GS have nothing to declare. MV: Chief editor of Pain Research and Management; editorial board of Journal Head Pain, Clinical Neurophysiology, European Journal of Pain, Neurological Sciences. LP: member of the Junior Editorial Board of The Journal of Headache and Pain, Section Board Member for Children in the area of Pediatric Neurology & Neurodevelopmental Disorders, Editorial Board Member of Confinia Cephalalgica, and Associate Editor for the Pediatric Neurology section of Frontiers in Neurology. She has received financial support from TEVA, Eli Lilly, Lundbeck, Pfizer, AbbVie, and Epitech for the organization of scientific meetings and support from attending meetings from MERCK and Biogen.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}